Healx

Powering therapies for rare diseases through artificial intelligence

Powering therapies for rare diseases through artificial intelligence

Healx’s combination of AI technology, drug discovery and rare disease expertise helps pharmaceutical and biotech companies accelerate orphan drug development. We work with companies worldwide to maximise the value of their pipelines through indication expansion, shelved asset revival and identification of new therapeutic combinations.

We have also generated a robust pipeline of rare disease assets, across a number of therapeutic areas, that are commercially viable and well differentiated. Please contact us for more information on current out-licensing and partnering opportunities.

Healnet. The AI platform for rare diseases

Rare diseases

Rare diseases

Proprietary database covering over 7,000 rare diseases.

Knowledge base

Knowledge base

Mapping billions of
drug-disease interactions.

Artificial intelligence

Artificial intelligence

State of the art artificial intelligence from Cambridge University.

Dr David Brown, Healx Co-Founder and Chairman. 
Co-inventor of Viagra. Ex-Global Head of Drug Discovery, Roche.

"After 40 years in drug discovery I am sure it is time for a radical rethink. Healx is helping to completely transform the traditional drug discovery model, not just trying to fix its broken parts."

Dr David Brown, Healx Co-Founder and Chairman. Co-inventor of Viagra. Ex-Global Head of Drug Discovery, Roche.

Healx solutions

Get in touch with Healx

Our technology

We use artificial intelligence to analyse vast amounts of data, coupled with deep rare disease and pharmacology expertise.

Learn More

About Healx

Meet our leadership team, board of directors and our scientific advisory board.

Learn More

Download Healx Rare Treatment Award application form

`